Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07339943
What this trial is testing

Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness

Who this might be right for
Prostate Cancer (Adenocarcinoma)Low and Intermediate Risk Prostate Cancer
University Health Network, Toronto 7
Not applicableEnded earlyNCT00619515
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 73
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT05764005
What this trial is testing

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 39
Not applicableNot Yet RecruitingNCT07526675
What this trial is testing

Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer

Who this might be right for
Prostate CancerLower Urinary Tract Symptoms (LUTS)Benign Prostatic Hyperplasia
Benha University 30
Not applicableActive Not RecruitingNCT01653925
What this trial is testing

Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression

Who this might be right for
Prostatic NeoplasmsLow Grade Prostate Cancer
CHU de Quebec-Universite Laval 120
Testing effectiveness (Phase 2)WithdrawnNCT04569461
What this trial is testing

Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)

Who this might be right for
Prostate Cancer
Duke University
Testing effectiveness (Phase 2)Study completedNCT03088124
What this trial is testing

Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer

Who this might be right for
Low Risk Prostate Cancer
Institut Paoli-Calmettes 93
Testing effectiveness (Phase 2)Study completedNCT03679260
What this trial is testing

Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance

Who this might be right for
Prostate Cancer
Cedars-Sinai Medical Center 22
Not applicableStudy completedNCT03790995
What this trial is testing

Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP

Who this might be right for
Prostate CancerQuality of LifeErectile Function+1 more
KU Leuven 9,235
Not applicableEnded earlyNCT01918605
What this trial is testing

Protection of Rectum From High Radiation Doses Using a Spacer

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms, MaleUrogenital Neoplasms+1 more
University of Oulu 5
Not applicableUnknownNCT04177056
What this trial is testing

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief

Who this might be right for
Bone MetastasesProstate CancerBreast Cancer+2 more
Hamilton Health Sciences Corporation 40
Testing effectiveness (Phase 2)Ended earlyNCT02648919
What this trial is testing

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Hawaii 6
Not applicableStudy completedNCT03329742
What this trial is testing

Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Indiana University 2
Testing effectiveness (Phase 2)Study completedNCT00983710
What this trial is testing

Prostate Cancer Symptom Management for Low Literacy Men

Who this might be right for
Prostate Cancer
Baylor College of Medicine 108
Large-scale testing (Phase 3)Looking for participantsNCT07241416
What this trial is testing

A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Jiangsu HengRui Medicine Co., Ltd. 206
Early research (Phase 1)UnknownNCT00009750
What this trial is testing

Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
University of California, Davis
Not applicableUnknownNCT04656678
What this trial is testing

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Disease
Northwell Health 200
Testing effectiveness (Phase 2)UnknownNCT01803503
What this trial is testing

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Who this might be right for
Solid TumorsBreast CancerNon-small Cell Lung Cancer+2 more
National University Hospital, Singapore 80
Large-scale testing (Phase 3)Study completedNCT01715285
What this trial is testing

Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 1,209
Next Page